Fluorinated Ether Protecting Groups for RNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for the chemical synthesis of RNA are inefficient and produce poor-quality products due to challenges in stabilizing and removing 2'-hydroxyl protecting groups, leading to issues like internucleotide bond instability and degradation during deprotection steps.
Innovation Solution
The development of nucleotide monomers with optimized 2'-hydroxyl protecting groups, such as orthoester and acetal derivatives, that can be regioselectively introduced and removed under mild acidic conditions without affecting the RNA integrity, allowing for efficient synthesis and deprotection of RNA sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If acid-stable 2'-protecting groups are used to prevent isomerization and cleavage during acid deprotection, then stability of the internucleotide bond is improved, but the protecting groups become base-labile or nucleophile-labile requiring strong base or strong nucleophile for removal which cleaves the internucleotide bond
Solution Approach 1:
The patent changes the chemical parameters of the protecting groups by introducing fluorinated alkyl groups (such as CF3CH2O- and CF3CH2CH2O-) that modify the stability characteristics. These fluorinated groups provide acid stability during deprotection while being removable under mild basic conditions (pH 7-9) that do not cleave the internucleotide bond, thus resolving the contradiction between bond stability and product integrity
Solution Approach 2:
The patent creates composite protecting group structures combining fluorinated alkyl chains with ether linkages (R-O-CH2-CF3 or R-O-CH2-CH2-CF3) attached to the 2'-hydroxyl. This composite structure provides both acid stability for bond protection and controlled base lability for gentle removal, simultaneously achieving both contradictory requirements
2Ease of operation
If general base-labile protecting groups are used for 2'-hydroxyl protection, then removal under mild conditions is achieved, but proton abstraction from the 2'-hydroxyl at pH above 11 causes rapid cleavage of the internucleotide bond
Solution Approach 1:
The fluorinated ether protecting groups are designed with specific pKa values that allow deprotection at controlled pH levels (7-9), well below the critical pH 11 threshold. This parameter optimization enables easy deprotection operations while maintaining internucleotide bond stability throughout the process
3Ease of manufacture
If nucleophile-labile protecting groups are used for 2'-hydroxyl protection, then removal by nucleophiles is achieved, but strong nucleophiles are also strong bases causing destruction of RNA through proton abstraction and internucleotide bond cleavage
Solution Approach 1:
The fluorinated ether groups modify the nucleophilic susceptibility of the protecting group while maintaining ease of removal. The electron-withdrawing fluorinated chains make the ether oxygen more susceptible to nucleophilic attack under mild conditions, allowing deprotection with weak nucleophiles at pH 7-9 that do not cause bond cleavage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of high-quality RNA with improved coupling efficiency and longer sequence lengths, overcoming previous limitations in RNA synthesis by stabilizing the 2'-hydroxyl protecting groups during synthesis and deprotection, thus enhancing the robustness and simplicity of the RNA synthesis process.
Implementation Method 1
deprotecting the 2'-hydroxyl protecting group and the base protecting groups by treating the polynucleotide with a solution of an α-effect nucleophile
Implementation Method 2
a solution of an α-effect nucleophile, wherein the solution is at a pH of about 4 to 10, wherein the α-effect nucleophile has a pKa of about 4 to 13
Data Source
Figure 1
Figure 2A~2C
Figure 2D~2E
AI summary
2'-O protected nucleotide monomers for the synthesis of RNA.